Regeneron Pharmaceuticals, Inc. Price — Chart — Historical Data
828.50
-5.54 (-0.66%)
REGN
| %Chg | Weekly | Monthly | YTD | YoY | |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | -0.66% | 2.25% | 26.29% | 6.72% | 44.75% |
Latest Regeneron Pharmaceuticals, Inc. News
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 ↗
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly…
Newsfile Corp · Aug 24, 17:35 UTC
The debt-fueled AI build-out may already be too big to fail ↗
The Federal Reserve’s pandemic corporate credit facilities have capped downside risks and remain part of its tool kit, says BofA Global
MarketWatch · Aug 25, 11:12 UTC
Stick with value stocks until everyone is talking about them — and they are still under the radar, this Wall Street firm says. ↗
BofA says investors continue to overlook value stocks, which work particularly well in a new era of higher interest rates and inflation.
MarketWatch · Aug 25, 11:09 UTC
Oil prices decline as investors brush aside Bessent’s ‘economic D-Day’ for Iran ↗
West Texas Intermediate and Brent crude’s contracts for October delivery both declined by about 3%.
MarketWatch · Aug 25, 10:45 UTC
New Delhi draws in $73 billion in 11 weeks, powered by special deposits for non-resident Indians ↗
India has attracted inflows of $73 billion in 11 weeks, driven mostly by foreign currency bank deposits made by non-resident Indians.
CNBC · Aug 25, 10:23 UTC
Gold hovers near three-month high on dollar weakness, Treasury bond buyback plans ↗
Gold prices fell Tuesday after rising to their highest in over three months.
CNBC · Aug 25, 10:23 UTC
Related
| Related | Price | %Chg |
|---|---|---|
| AbbVie Inc. | 264.52 | -0.17% |
| Abbott Laboratories | 116.67 | 0.03% |
| Amgen Inc. | 443.84 | 1.03% |
| Cigna Corporation | 280.45 | 1.06% |
| Danaher Corporation | 215.20 | -1.67% |
| Elevance Health Inc. | 402.63 | 0.52% |
| Eli Lilly and Company | 1,247.9 | -0.60% |
| Gilead Sciences, Inc. | 146.74 | 0.42% |